Rhenman & Partners Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-33,000
Closed -$2.96M 103
2025
Q1
$2.96M Sell
33,000
-244,500
-88% -$22.8M 0.34% 62
2024
Q4
$27.6M Buy
277,500
+36,500
+15% +$3.76M 2.84% 8
2024
Q3
$27.4M Buy
241,000
+66,000
+38% +$7.84M 2.22% 15
2024
Q2
$21.7M Sell
175,000
-43,500
-20% -$5.6M 2.08% 16
2024
Q1
$28.8M Buy
218,500
+71,000
+48% +$8.75M 2.73% 10
2023
Q4
$16.1M Sell
147,500
-42,500
-22% -$4.41M 1.61% 22
2023
Q3
$19.6M Hold
190,000
2.11% 19
2023
Q2
$21.9M Sell
190,000
-51,000
-21% -$5.79M 2.31% 15
2023
Q1
$25.5M Buy
241,000
+26,000
+12% +$2.81M 2.8% 7
2022
Q4
$23.9M Hold
215,000
2.49% 7
2022
Q3
$21.8M Sell
215,000
-50,000
-19% -$4.46M 2.28% 11
2022
Q2
$24.2M Buy
265,000
+40,000
+18% +$3.55M 2.75% 12
2022
Q1
$18.5M Sell
225,000
-75,000
-25% -$5.91M 1.82% 19
2021
Q4
$23.1M Hold
300,000
1.54% 21
2021
Q3
$22.5M Hold
300,000
1.58% 22
2021
Q2
$23.3M Buy
300,000
+17,040
+6% +$1.27M 1.58% 21
2021
Q1
$20.8M Sell
282,960
-77,573
-22% -$5.72M 1.45% 27
2020
Q4
$28.1M Buy
360,533
+192,853
+115% +$14.7M 2.3% 10
2020
Q3
$13.3M Hold
167,680
1.18% 36
2020
Q2
$12.4M Sell
167,680
-5,240
-3% -$394K 1.34% 31
2020
Q1
$12.7M Buy
172,920
+5,240
+3% +$412K 1.78% 19
2019
Q4
$14.6M Sell
167,680
-57,640
-26% -$4.73M 1.59% 25
2019
Q3
$18.1M Buy
+225,320
New +$18.1M 2.27% 14
2017
Q4
Sell
-94,320
Closed -$5.76M 97
2017
Q3
$5.76M Sell
94,320
-52,400
-36% -$3.18M 0.74% 54
2017
Q2
$8.97M Sell
146,720
-20,960
-13% -$1.28M 1.29% 27
2017
Q1
$10.2M Buy
167,680
+94,320
+129% +$5.72M 1.61% 26
2016
Q4
$4.12M Sell
73,360
-136,240
-65% -$7.97M 0.79% 51
2016
Q3
$12.5M Buy
+209,600
New +$12.3M 1.98% 15
2015
Q4
Sell
-104,800
Closed -$4.94M 98
2015
Q3
$4.94M Sell
104,800
-167,680
-62% -$8.91M 0.79% 51
2015
Q2
$14.8M Sell
272,480
-41,920
-13% -$2.35M 1.78% 14
2015
Q1
$17.2M Buy
314,400
+230,560
+275% +$13.1M 2.91% 4
2014
Q4
$4.54M Buy
83,840
+15,720
+23% +$876K 1.32% 26
2014
Q3
$3.85M Sell
68,120
-13,624
-17% -$765K 1.13% 34
2014
Q2
$4.51M Buy
81,744
+1,415
+2% +$77.2K 1.34% 21
2014
Q1
$4.35M Sell
80,329
-8,751
-10% -$453K 1.31% 22
2013
Q4
$4.25M Buy
+89,080
New +$4.07M 1.66% 20

Other funds holding MRK

Rhenman & Partners Asset Management's MRK Position: Q2 2025 in Review

Rhenman & Partners Asset Management sold out of Merck (MRK) in Q2 2025, closing a stake of 33,000 shares — an estimated $2.96M sold.

Rhenman & Partners Asset Management first reported a position in MRK in Q4 2013 and held it in 36 quarters. The position peaked at $28.8M in Q1 2024. 3,328 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Rhenman & Partners Asset Management reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 33,000 Merck shares in Q2 2025, an estimated $2.96M.
  • Rhenman & Partners Asset Management first reported a position in Merck in Q4 2013 and held it in 36 quarters.
  • Rhenman & Partners Asset Management's Merck position peaked at $28.8M in Q1 2024.
  • 3,328 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.